NCT05840094

Multimodalitic Imaging in the N-stage of Lung Cancer

A Prospective Study of the Predictive and Prognostic Value of Multimodalitic Imaging in the N-stage of Lung Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Peking University First Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study aims to evaluate the diagnostic efficacy and differences between 18F-FDG PET/CT and MR STIR sequences combined with EBUS-TBNA, 18F-FDG PET/CT combined with EBUS-TBNA, and MR STIR sequences combined with EBUS-TBNA - three types of multimodal imaging for assessing NSCLC N-stage, in order to select the best assessment protocol to guide treatment decisions and prognostic assessments.

Conditions

• Neoplasm of Lung

Interventions

Type	Name	Description
DRUG	18F-FDG	18F-FDG is injected intravenously with a dose of 0.1mCi/kg.
DEVICE	MR STIR	The overall scanning time of MR is about 13min.
PROCEDURE	EBUS-TBNA	Puncture about 20 times, 3 stitches in each group of enlarged lymph nodes, 1 stitch in the anterior, middle and posterior parts respectively

Timeline

• Start date: 2023-05-01
• Primary completion: 2025-05-01
• Completion: 2025-05-01
• First posted: 2023-05-03
• Last updated: 2023-05-03

Locations

1 site across 1 country: China